Meixiang Li
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Case Report: Tumor regression and neurological recovery in paraplegia from POLD1-mutated hepatocellular carcinoma treated with targeted immunotherapy and electroacupuncture.
Journal: Frontiers in immunology
Published: December 27, 2025
The role of Treg cells in colorectal cancer and the immunotherapy targeting Treg cells.
Journal: Frontiers in immunology
Published: February 10, 2025
CXCR4 up-regulation mediated by USP1 deubiquitination promotes the tumorigenesis and immune escape in esophageal squamous-cell carcinoma.
Journal: Journal of biochemical and molecular toxicology
Published: March 20, 2024
Circ_0000395 promotes cell growth, metastasis and oxaliplatin resistance by regulating miR-153-5p/MYO6 in colorectal cancer.
Journal: Pathology, research and practice
Published: March 05, 2024
CircSCMH1 Accelerates Sorafenib Resistance in Hepatocellular Carcinoma by Regulating HN1 Expression via miR-485-5p.
Journal: Molecular biotechnology
Published: August 25, 2023
Circ_0058058 Drives the Malignant Phenotypes and Immune Evasion of Pancreatic Cancer by the MicroRNA-557-Dependent Regulation of PDL1.
Journal: Pancreas
Published: April 26, 2023
MiR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer.
Journal: Biochemical and biophysical research communications
Published: July 14, 2021
Durable benefit from immunotherapy and accompanied lupus erythematosus in pancreatic adenocarcinoma with DNA repair deficiency.
Journal: Journal for immunotherapy of cancer
Published: June 09, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026